Celine Halioua is the CEO and Founder of Loyal, a biotech startup developing drugs to extend dog lifespan. BUT with a twist! If this life-extension research and drug development works for canines, her theory is that it could lead to breakthroughs for the rest of us humans for age related diseases! Previously, she held various roles at The Longevity Fund, an early stage venture capital fund investing in companies developing therapeutics to treat aging. Celine has a technical background in neuroscience and gene therapy. She holds a B.Sc. in neuroscience from the University of Texas at Austin and was a D.Phil. student at Oxford University. She worked in the laboratories of Dr. Evan Snyder at the Sanford-Burnham-Prebys Medical Discovery Institute on novel enteric neuron disease therapeutics, and of Dr. Richard Morrisett and Dr. Keith Stevenson at The University of Texas at Austin on the development of novel silver-nanocluster neuronal tracers for applications in neuropharmacology.
WHAT YOU WILL LEARN IN THIS EPISODE
Full show notes, transcripts, and resources can be found here: evolvethe.world/episodes/68
TIMESTAMPS
(00:00) - Podcast Recommendation - #impact with Regina Larko
(00:43) - Introduction
(02:17) - Celine's Mission For Better Medicine and Healthcare
(04:40) - Why dog longevity to fix human illness
(07:11) - Why Celine cares so much about longevity
(09:39) - What's wrong with the longevity field
(11:57) - What does longevity actually look like
(14:04) - What is Loyal for dogs and what is it creating
(18:33) - How Celine wants to inspire other biotech founders
(20:25) - How to manage senior talent as a young founder
(21:59) - How to go from academia to startups
(26:25) - The first step for creating a biotech company
(28:00) - Mental models, self awareness, and emotional challenges as a found
(34:12) - Sacrifice and personal responsibility
(35:32) - Are we all delaying our own mortality
(36:35) - Call to Action
(37:24) - How to push the world to Evolve